Detection of the BRAF V600E mutation in melanocytic lesions using the ligase detection reaction

Daniel J Turner1, Monib A Zirvi, Francis Barany

  • 1Department of Microbiology, Cornell University Graduate School of Medical Sciences, New York, NY, USA.

Abstract

Insights

The ligase detection reaction (LDR) accurately detects BRAF V600E mutations in skin lesions. This method confirms the absence of this mutation in Spitz nevi, aiding in their distinction from other nevi and melanomas.

Area of Science:

  • Oncology
  • Genetics
  • Dermatopathology

Background:

  • BRAF kinase is crucial in the RAS-MAP kinase signaling cascade.
  • Activating BRAF V600E mutations are common in melanomas and nevi.
  • These mutations are notably absent in uveal melanomas and Spitz nevi.

Purpose of the Study:

  • To evaluate the ligase detection reaction (LDR) for detecting BRAF mutations in various skin lesions.
  • To determine the presence or absence of the BRAF V600E mutation in Spitz nevi.

Main Methods:

  • Utilized ligase detection reaction (LDR), a sensitive DNA mutation detection technique.
  • Analyzed DNA from paraffin-embedded tissue sections of common nevi, dysplastic nevi, melanomas, and Spitz nevi.

Main Results:

  • LDR successfully detected BRAF mutations in common nevi, dysplastic nevi, and melanomas.
  • The BRAF V600E (T1799A) mutation was confirmed to be absent in Spitz nevi.

Conclusions:

  • LDR is a sensitive and specific method for mutation detection in formalin-fixed tissues.
  • The absence of the BRAF V600E mutation can serve as a molecular marker to differentiate Spitz nevi from other skin lesions.